๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum adiponectin in chronic hepatitis C and B

โœ Scribed by D. Siagris; G. Vafiadis; M. Michalaki; A. Lekkou; I. Starakis; M. Makri; V. Margaritis; M. Christofidou; A. C. Tsamandas; C. Labropoulou-Karatza

Book ID
108886004
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
448 KB
Volume
14
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

P1890 Serum adiponectin in chronic hepat
P1890 Serum adiponectin in chronic hepatitis C and B
โœ Siagris, D.; Lekkou, A.; Vafiadis, G.; Michalaki, M.; Starakis, I.; Makri, M.; M ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 56 KB
Adiponectin in chronic hepatitis C
Adiponectin in chronic hepatitis C
โœ Arano, Toru; Nakagawa, Hayato; Ikeda, Hitoshi; Koike, Kazuhiko ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Springer Japan ๐ŸŒ English โš– 143 KB
Serum level of adiponectin and the risk
Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients
โœ Toru Arano; Hayato Nakagawa; Ryosuke Tateishi; Hitoshi Ikeda; Koji Uchino; Kenic ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 321 KB ๐Ÿ‘ 1 views

## Abstract Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC). Dysregulation of adipokines, particularly the decreased secretion of adiponectin, appears to play a key role. To investigate the assoc